76 results
Page 2 of 4
8-K
EX-99.1
sdhufpam qghyfy9x
5 May 22
Prothena Reports First Quarter 2022 Financial Results and Business Highlights
12:00am
8-K
EX-99.1
38alo8lsonpeuxdj1
17 Feb 22
Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidance and Business Highlights
4:07pm
8-K
EX-1.1
gyyy93zvmuc8q
23 Dec 21
Other Events
5:18pm
8-K
EX-99.1
epltlud99f9o8cwz7n59
4 Nov 21
Prothena Reports Third Quarter 2021 Financial Results and Business Highlights
4:18pm
8-K
EX-99.1
oiro74exopopn64on
5 Aug 21
Prothena Reports Second Quarter 2021 Financial Results and Business Highlights
4:11pm
8-K
EX-1.1
0sxx0xsre5
28 May 21
Other Events
5:11pm
8-K
EX-99.1
eln7b77dt0f1 cv70p
11 May 21
Prothena Reports First Quarter 2021 Financial Results, and Provides Updated Financial Guidance and R&D Update
4:07pm
8-K
EX-1.1
u9zv6
26 Mar 21
Other Events
4:06pm
424B5
uqjpw9z d3a82z
24 Mar 21
Prospectus supplement for primary offering
4:01pm
424B5
zr4k6
23 Mar 21
Prospectus supplement for primary offering
5:13pm
8-K
EX-99.1
7nlhqznc8v987o
11 Feb 21
Prothena Reports Fourth Quarter and Full Year 2020 Financial Results, and Provides Financial Guidance and R&D Update
8:02am
8-K
EX-99.1
05ok36uerp73 usmuf
1 Feb 21
Prothena Announces Confirmatory Phase 3 AFFIRM-AL Study of Birtamimab in Mayo Stage IV Patients with AL Amyloidosis under SPA Agreement with FDA
4:16pm